首页> 外国专利> 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them

1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them

机译:1-(1,2-二取代的哌啶基)-4-(稠合的咪唑)-哌啶衍生物,其制备方法和中间体,其用途以及含有它们的药物组合物

摘要

This invention concerns the compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 0, 1 or 2; m is 1 or 2, provided that if m is 2, then n is 1; =Q is =O or =NR3; X is a covalent bond or -O-, -S-, -NR3-; R1 is Ar1, Ar1C1-6alkyl or di(Ar1)C1-6alkyl, wherein each C1-6alkyl group is optionally substituted; R2 is Ar2, Ar2C1-6alkyl, Het or HetC1-6 alkyl; R3 is hydrogen or C1-6alkyl; L is a piperidine derivative of formula (a-1) or a spiro piperidine derivative of formula (a-2); Ar1 is phenyl or substituted phenyl; Ar2 is naphtalenyl; phenyl or substituted phenyl; and Het is a monocyclic or bicyclic heterocycle; each monocyclic and bicyclic heterocycle may optionally be substituted on a carbon atom; as substance P antagonists; their preparation, compositions containing them and their use as a medicine.
机译:本发明涉及式(Ⅰ)化合物,其N-氧化物形式,其药学上可接受的加成盐及其立体化学异构形式,其中n为0、1或2; n为0。 m为1或2,如果m为2,则n为1; = Q是= O或= NR3; X是共价键或-O-,-S-,-NR3-; R1是Ar1,Ar1C1-6烷基或二(Ar1)C1-6烷基,其中每个C1-6烷基是任选取代的; R2为Ar2,Ar2C1-6烷基,Het或HetC1-6烷基; R3是氢或C1-6烷基; L为式(a-1)的哌啶衍生物或式(a-2)的螺哌啶衍生物。 Ar1为苯基或取代的苯基; Ar 2是萘基;苯基或取代的苯基; Het是单环或双环杂环;每个单环和双环杂环可任选地在碳原子上被取代;作为P物质拮抗剂;它们的制剂,包含它们的组合物及其作为药物的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号